Clinical Trials Browser

Phase 1/2 × Rectal Neoplasms × Hydralazine × Clear all

NCT00575640 2015-03-04

Hydralazine as a Demethylating Agent in Rectal Cancer

Phase 1/2 Withdrawn

Gastrointestinal

Rectal Neoplasms